Literature DB >> 23786153

Identification of intravascular tumor microenvironment features predicting the recurrence of pathological stage I lung adenocarcinoma.

Kaoru Kaseda1, Genichiro Ishii, Keiju Aokage, Akiko Takahashi, Takeshi Kuwata, Tomoyuki Hishida, Junji Yoshida, Mitsutomo Kohno, Kanji Nagai, Atsushi Ochiai.   

Abstract

Histological vascular invasion (VI) by tumors is reportedly a risk factor influencing recurrence or survival after surgical treatment; however, few studies have evaluated which VI features affect recurrence or survival. The objective of this study was to evaluate how VI features affect recurrence in lung adenocarcinoma patients. We selected 106 patients with pathological stage I lung adenocarcinoma who showed VI and examined the properties of intravascular tumors associated with recurrence. First we investigated the relationship between the frequency of VI in a histological cross-section and the incidence of recurrence; however, a significant impact was not observed. Microscopic examination revealed the intravascular tumors were composed of not only cancer cells but also non-cancerous cells. To examine whether the characteristics of intravascular cancer cells and/or non-cancerous cells have prognostic value, we examined the expression levels of epithelial-mesenchymal transition-related markers in cancer cells and the numbers of infiltrating non-cancerous cells, including macrophages, endothelial cells, and fibroblasts. High levels of E-cadherin expression in the intravascular cancer cells were significant predictors of recurrence (P = 0.004), whereas the expressions of CD44, CD44 variant 6, and vimentin were not. Large numbers of intravascular CD204(+) macrophages (P = 0.016), CD34(+) microvessels (P = 0.007), and α-smooth muscle actin (+) fibroblasts (P = 0.033) were also significant predictors of recurrence. Our results indicated VI with abundant stromal cell infiltrates might be a predictor of recurrence and suggested the tumor microenvironment created by cancer cells and stromal cells within the blood vessel may play an important role during the metastatic process.
© 2013 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23786153     DOI: 10.1111/cas.12219

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  10 in total

1.  Prognostic factors of patients with pathologic stage I lung adenocarcinoma.

Authors:  Ying-Yi Chen; Tsai-Wang Huang
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

2.  Prognostic value of the frequency of vascular invasion in stage I non-small cell lung cancer.

Authors:  Satoshi Okada; Shinjiro Mizuguchi; Nobuhiro Izumi; Hiroaki Komatsu; Michihito Toda; Kantaro Hara; Takahiro Okuno; Toshihiko Shibata; Hideki Wanibuchi; Noritoshi Nishiyama
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-10-13

3.  Transcription factors related to epithelial mesenchymal transition in tumor center and margin in invasive lung adenocarcinoma.

Authors:  Young-In Maeng; Kyung-Hyun Kim; Jung-Yeon Kim; Sun-Jae Lee; Woo-Jung Sung; Chong-Kee Lee; Jae-Bok Park; Kwan-Kyu Park
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

4.  Priming cancer cells for drug resistance: role of the fibroblast niche.

Authors:  Wei Bin Fang; Min Yao; Nikki Cheng
Journal:  Front Biol (Beijing)       Date:  2014-02-01

5.  The association of intravascular stromal cells with prognosis in high-grade neuroendocrine carcinoma of the lung.

Authors:  Keigo Sekihara; Tomoyuki Hishida; Shinnosuke Ikemura; Koichi Saruwatari; Masahiro Morise; Takeshi Kuwata; Satoshi Fujii; Motohiro Kojima; Atsushi Ochiai; Kazuhito Funai; Keiju Aokage; Junji Yoshida; Masahiro Tsuboi; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-22       Impact factor: 4.553

6.  Unique intravascular tumor microenvironment predicting recurrence of lung squamous cell carcinoma.

Authors:  Kakeru Hisakane; Koichi Saruwatari; Satoshi Fujii; Keisuke Kirita; Shigeki Umemura; Shingo Matsumoto; Kiyotaka Yoh; Seiji Niho; Hironobu Ohmatsu; Takeshi Kuwata; Atsushi Ochiai; Akihiko Gemma; Masahiro Tsuboi; Koichi Goto; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2015-10-31       Impact factor: 4.553

7.  Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.

Authors:  Rurika Hamanaka; Tomoyuki Yokose; Yuji Sakuma; Masahiro Tsuboi; Hiroyuki Ito; Haruhiko Nakayama; Kouzo Yamada; Ryota Masuda; Masayuki Iwazaki
Journal:  Diagn Pathol       Date:  2015-04-02       Impact factor: 2.644

8.  Prognostic impact of count of extratumoral lymphatic permeation in lung adenocarcinoma and its relation to the immune microenvironment.

Authors:  Takahiro Niimi; Tokiko Nakai; Keiju Aokage; Kenta Tane; Tomohiro Miyoshi; Joji Samejima; Saori Miyazaki; Tetsuro Taki; Naoya Sakamoto; Shingo Sakashita; Reiko Watanabe; Motohiro Kojima; Kenji Suzuki; Masahiro Tsuboi; Genichiro Ishii
Journal:  Cancer Sci       Date:  2022-02-19       Impact factor: 6.716

9.  Oncogenic role of miR‑183‑5p in lung adenocarcinoma: A comprehensive study of qPCR, in vitro experiments and bioinformatic analysis.

Authors:  Rong-Quan He; Li Gao; Jie Ma; Zu-Yun Li; Xiao-Hua Hu; Gang Chen
Journal:  Oncol Rep       Date:  2018-05-09       Impact factor: 3.906

10.  Relationship between stromal cells and tumor spread through air spaces in lung adenocarcinoma.

Authors:  Xie Qiu; Donglai Chen; Yangyang Liu; Shanzhou Duan; Fuquan Zhang; Yongsheng Zhang; Feng Li; Chang Chen; Yongbing Chen
Journal:  Thorac Cancer       Date:  2019-01-03       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.